- Somers, E. C., Marder, W., Cagnoli, P., Lewis, E. E., DeGuire, P., Gordon, C., ... & McCune, W. J. (2014). Population‐based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program. Arthritis & rheumatology, 66(2), 369-378.
- Sproston, N. R., & Ashworth, J. J. (2018). Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018; 9: 754. URL: https://www. frontiersin. org/articles/10.3389/fimmu.
- Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016). New insights into the immunopathogenesis of systemic lupus erythematosus. Nature Reviews Rheumatology, 12(12), 716-730.
- Touma, Z., Gladman, D. D., Ibañez, D., & Urowitz, M. B. (2011). Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50. The Journal of rheumatology, 38(2), 275-284.
- Cambridge, G., Wallace, H., Bernstein, R. M., & Leaker, B. (1994). Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Rheumatology, 33(2), 109-114.
- Telles, R. W., Ferreira, G. A., Silva, N. P. D., & Sato, E. I. (2010). Increased plasma myeloperoxidase levels in systemic lupus erythematosus. Rheumatology international, 30(6), 779-784.
- Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey‐Goldman, R., ... & Johnson, S. R. (2019). 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis & rheumatology, 71(9), 1400-1412.
- Weening, J. J., D'agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., ... & Nagata, M. (2004). The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney international, 65(2), 521-530.
- Mok C, Penn H, Chan K, Tse SM, Langman LJ , Jannetto PJ. 2016.Hydroxychloroquine serum concentrations and flares of systemic lupus erythematosus: a longitudinal cohort analysis. Arthritis Care Res. 68(9):1295–302.
- Nasr, S. H., D'Agati, V. D., Park, H. R., Sterman, P. L., Goyzueta, J. D., Dressler, R. M., ... & Markowitz, G. S. (2008). Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clinical Journal of the American Society of Nephrology, 3(3), 682-690.
- Jennette, J. C., Falk, R. J., Hu, P., & Xiao, H. (2013). Pathogenesis of antineutrophil cytoplasmic autoantibody–associated small-vessel vasculitis. Annual review of pathology, 8, 139.
- Pieterse, E., & van der Vlag, J. (2014). Breaking immunological tolerance in systemic lupus erythematosus. Frontiers in immunology, 5, 164.
- Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., ... & Zychlinsky, A. (2004). Neutrophil extracellular traps kill bacteria. science, 303(5663), 1532-1535.
- Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., ... & Zychlinsky, A. (2007). Novel cell death program leads to neutrophil extracellular traps. The Journal of cell biology, 176(2), 231-241.
- Hirai, Y., Iyoda, M., Shibata, T., Ashikaga, E., Hosaka, N., Suzuki, H., ... & Akizawa, T. (2008). Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia. Clinical and Experimental Nephrology, 12(5), 393-397.
- Said, D., Rashad, N. M., Abdelrahmanc, N. S., & Dawaa, G. A. (2021). Antineutrophil cytoplasmic antibody in lupus nephritis: correlation with clinicopathological characteristics and disease activity. Current Rheumatology Reviews, 17(2), 213-221.
- Morgan, P. E., Sturgess, A. D., & Davies, M. J. (2005). Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis & Rheumatism, 52(7), 2069-2079.
- Olson, S. W., Lee, J. J., Poirier, M., Little, D. J., Prince, L. K., Baker, T. P., ... & Abbott, K. C. (2017). Anti-myeloperoxidase antibodies associate with future proliferative lupus nephritis. Autoimmune diseases, 2017.
- Li, C., Wang, J. J., Zhou, M. L., Liang, D. D., Yang, J., Zhu, H. X., ... & Zhang, H. T. (2019). Differences in clinico-pathological characteristics and outcomes between proteinase 3-ANCA positivity and myeloperoxidase-ANCA positivity in lupus nephritis. Lupus, 28(9), 1111-1119.
- Yu, F., Tan, Y., Liu, G., Wang, S. X., Zou, W. Z., & Zhao, M. H. (2009). Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney international, 76(3), 307-317.
|